ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Athenex rakes in $100M, sets up Chinese TCR-focused JV
fiercebiotech
July 09, 2018Just over a year since its IPO, Athenex is?broadening?its scope—the biotech is picking up a $100 million investment from Perceptive Advisors, licensing a modified cancer-fighting enzyme and launching a new Chinese joint venture built around T-cell recepto
Pharma Sources Insight January 2025
